| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,986 | 1,050 | 11:20 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 15.09. | Modulight Oyj: Inside Information: Modulight has received a $1.5 million pilot production order from a U.S. neuroscience customer | 180 | GlobeNewswire (Europe) | Modulight Corporation | Inside Information | September 15, 2026 at 13:25:00 EEST
Modulight Corporation has received a $1.5 million pilot production purchase order from an existing U.S. venture customer... ► Artikel lesen | |
| 21.08. | Modulight Q2 2026 slides: margins surge 185% as revenue falls 18% | 2 | Investing.com | ||
| 21.08. | Earnings Call: Modulight steigert Margen im zweiten Quartal trotz Umsatzrückgang | - | Investing.com Deutsch | ||
| 21.08. | Earnings Call Transkript: Modulight meldet für Q2 2026 höhere Margen bei sinkendem Umsatz | - | Investing.com Deutsch | ||
| MODULIGHT Aktie jetzt für 0€ handeln | |||||
| 21.08. | Modulight Oyj Q2 Sales Decline | 1 | RTTNews | ||
| 04.05. | Modulight Oyj: Resolutions of Modulight Corporation's Annual General Meeting and Inaugural Meeting of the Board of Directors on 4 May 2026 | 260 | GlobeNewswire (Europe) | Modulight Corporation | Company Release | May 04, 2026 at 15:55:00 EEST
The Annual General Meeting of Modulight Corporation was held on 4 May 2026 at 1 p.m. (Finnish time) at Kampusareena Auditorium... ► Artikel lesen | |
| 24.04. | Modulight Oyj: Profitability improved despite the decline in revenue | 485 | GlobeNewswire (Europe) | Modulight Corporation | Company Release | April 24, 2026 at 10:30:00 EEST
This release is a summary of Modulight's interim report for January-March 2026. The whole report is attached to this stock exchange... ► Artikel lesen | |
| 21.04. | Modulight Oyj: Inside information: Modulight introduces financial guidance for 2026 | 230 | GlobeNewswire (Europe) | Modulight Corporation | Inside Information | April 21, 2026 at 15:21:00 EEST
Modulight Corporation announces that, as of today, the company will provide financial guidance on its revenue and EBITDA.... ► Artikel lesen | |
| 20.02. | Modulight Oyj: Record Year in Revenue Growth | 586 | GlobeNewswire (Europe) | Modulight Corporation | Company Release | February 20, 2026 at 11:00:00 EET
This release is a summary of Modulight's financial statements bulletin 2025. The whole report is attached to this stock exchange... ► Artikel lesen | |
| 24.10.25 | Modulight Oyj: Continued Improvement in Revenue and Profitability | 353 | GlobeNewswire (Europe) | Modulight Corporation | Company Release | October 24, 2025 at 13:00:00 EEST
This release is a summary of Modulight's interim report for January-September 2025. The whole report is attached to this stock... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| THERMO FISHER | 582,20 | +0,07 % | Thermo Fisher Scientific and Evosep Enter Reseller Agreement for Evosep Eno | Thermo Fisher Scientific to offer the Evosep Eno separation platform to customers, expanding access to standardized, high-throughput proteomics workflowsSINGAPORE, Sept. 28, 2026 (GLOBE NEWSWIRE) --... ► Artikel lesen | |
| NYXOAH | 1,190 | 0,00 % | Nyxoah Appoints Liam Kelly as Chief Executive Officer | REGULATED INFORMATIONINSIDE INFORMATION Nyxoah Appoints Liam Kelly as Chief Executive Officer Further strengthening the Company's strategic U.S. presence and focus Mont-Saint-Guibert, Belgium - September... ► Artikel lesen | |
| OPTOMED | 1,438 | -0,69 % | Optomed Oyj: Half-year report January - June 2026 | Optomed Plc Stock Exchange Release 14 August 2026 at 9.00, Helsinki
Optomed Plc: Half-year report January - June 2026
April - June 2026
Revenue decreased by 8.6 percent to EUR 3.5 (3.8) million.
Currency-adjusted... ► Artikel lesen | |
| NEXSTIM | 9,150 | 0,00 % | Original-Research: Nexstim (von NuWays AG): BUY | Original-Research: Nexstim - from NuWays AG
02.09.2026 / 09:00 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 11,830 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 60,27 | 0,00 % | BMO Capital reiterates Outperform on BrightSpring Health stock | ||
| BILLIONTOONE | 105,90 | 0,00 % | BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar | Renowned physician-scientist, former Director of Frederick National Laboratory, and one of the nation's most accomplished leaders in oncology joins BillionToOne... ► Artikel lesen | |
| HEARTFLOW | 49,270 | 0,00 % | AI Cardiac Diagnostics Pioneer Sets HeartFlow (HTFL) for High-Margin Expansion | ||
| PROCEPT BIOROBOTICS | 17,160 | 0,00 % | PROCEPT BioRobotics Corp - 8-K, Current Report | ||
| ALIGNMENT HEALTHCARE | 7,945 | 0,00 % | Are Options Traders Betting on a Big Move in Alignment Healthcare Stock? | ||
| SIEMENS HEALTHINEERS | 37,430 | +0,66 % | JEFFERIES stuft Siemens Healthineers auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Siemens Healthineers mit einem Kursziel von 50 Euro auf "Buy" belassen. Accela sei ein Quantensprung in der Strahlentherapie... ► Artikel lesen | |
| FRESENIUS | 44,140 | -0,38 % | Fresenius Kabi erhält Warnung von der US-Gesundheitsbehörde FDA | DJ Fresenius Kabi erhält Warnung von der US-Gesundheitsbehörde FDA
DOW JONES--Die Fresenius-Tochter Kabi hat einen Warnschuss von der US-Gesundheitsbehörde FDA erhalten. In dem am Dienstag veröffentlichten... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 30,340 | +0,32 % | Carl Zeiss Meditec: Das Chartbild sieht spannend aus, aber … | Nachdem Carl Zeiss Meditec im Januar eine Gewinnwarnung veröffentlichte und einbrach, gelang zwar eine Bodenbildung, aber zurück in den Fokus der Käufer gelangte die Aktie nicht mehr. Doch jetzt sieht... ► Artikel lesen | |
| QTREX QUANTUM | 1,100 | 0,00 % | Qtrex Quantum jumps 40% | ||
| GENEDX | 73,03 | 0,00 % | GeneDx: Starkes Wachstum trifft auf schwachen Forderungseinzug |